具有动态性性酸类型金属β-乳糖酶抑制剂
Kinga Virág Gulyás1, Liping Zhou2, Daniel Salamonsen3
1Department of Chemistry - BMC, Organic Chemistry and the Uppsala Antibiotic Center; Uppsala University, Uppsala, Sweden.
Communications chemistry
|April 19, 2025
概括
新的动态性酸抑制金属β-乳糖酶酶,为抗生素耐药性提供了一个有前途的策略. 这些化合物是无毒的和适应性的,可能会阻碍细菌.
科学领域:
- 药用化学 医学化学
- 生物化学 生化学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 抗生素耐药性,特别是金属β-乳糖酶 (MBL) 介导的耐药性,对全球健康构成重大威胁.
- MBLs使宽谱β-乳糖抗生素失活,限制了治疗选择.
- 目前,对于MBLs没有临床批准的抑制剂.
研究的目的:
- 开发针对金属β-乳酸酶 (MBLs) 的新型抑制剂,能够适应结构变异.
- 研究动态性酸作为MBL抑制剂的潜力.
主要方法:
- 动态性酸的合成.
- 评估细菌穿透膜的情况.
- 在体外抑制对NDM-1,VIM-2和GIM-1MBL的测定.
- 在人体细胞上进行细胞毒性测试.
主要成果:
- 合成了动态性酸,并证明有效抑制了NDM-1,VIM-2和GIM-1.
- 这些化合物具有良好的细菌膜透性,对人体细胞无毒.
- 酸的两种立体异构体都与MBL活性部位结合,准Zn离子并模仿过渡状态.
结论:
- 动态性酸代表了一类新的MBL抑制剂,具有广泛的适用性.
- 它们对酶结构多样性和双立体异构体结合的适应性可能会克服耐药性的发展.
- 这些发现为对抗由MBL产生细菌引起的感染提供了有希望的途径.
更多相关视频
07:47Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
10.6K
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.0K
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
473
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
473
